<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="1139">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on December 16, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05146323</url>
  </required_header>
  <id_info>
    <org_study_id>2021-06Obs-CHRMT</org_study_id>
    <nct_id>NCT05146323</nct_id>
  </id_info>
  <brief_title>Optimization of 99mTc-Sestamibi Activities in SPECT/CT Myocardial Perfusion Imaging</brief_title>
  <acronym>OSPECT</acronym>
  <official_title>Personalization of 99mTc-Sestamibi Activities in SPECT/CT Myocardial Perfusion Imaging With the Cardiofocal SmartZoom® Collimator</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Régional Metz-Thionville</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre Hospitalier Régional Metz-Thionville</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This work suggests a methodology to adapt the injected radionuclide activity to the level of&#xD;
      attenuation of each patient. The investigators propose a dose reduction adapted to the&#xD;
      patient's weight, with no significant degradation of the image quality, in order to improve&#xD;
      patients and staff radioprotection, standardize the image quality for easier clinical&#xD;
      interpretation, and lead to radiopharmaceutical saving in the context of myocardial perfusion&#xD;
      Imaging.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">February 11, 2021</start_date>
  <completion_date type="Actual">September 24, 2021</completion_date>
  <primary_completion_date type="Actual">June 30, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Number of counts</measure>
    <time_frame>Day 1</time_frame>
    <description>Number of counts in the myocardial region of interest</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Clinical evaluation</measure>
    <time_frame>Day 1</time_frame>
    <description>Medical evaluation of image quality, in order to establish a correlation between the myocardial signal level and the clinical image quality</description>
  </secondary_outcome>
  <enrollment type="Actual">294</enrollment>
  <condition>Coronary Heart Disease</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Patient with myocardial perfusion Imaging in the context of coronary heart disease&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patient underwent stress-test 99 mTc-Sestamibi SPECT/CT myocardial perfusion Imaging&#xD;
             on a Siemens Intevo Bold Anger camera with the cardiofocal SmartZoom® collimator&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  None&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>CHR Metz Thionville</name>
      <address>
        <city>Metz</city>
        <state>Moselle</state>
        <zip>57085</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>November 2021</verification_date>
  <study_first_submitted>November 23, 2021</study_first_submitted>
  <study_first_submitted_qc>November 23, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">December 6, 2021</study_first_posted>
  <last_update_submitted>November 23, 2021</last_update_submitted>
  <last_update_submitted_qc>November 23, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">December 6, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Myocardial SPECT</keyword>
  <keyword>Sestamibi</keyword>
  <keyword>SmartZoom</keyword>
  <keyword>Cardiofocal collimator</keyword>
  <keyword>Dose optimization</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Diseases</mesh_term>
    <mesh_term>Coronary Disease</mesh_term>
    <mesh_term>Coronary Artery Disease</mesh_term>
    <mesh_term>Myocardial Ischemia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

